Watch Regeneron, UPS, Zebra, and More
Market Watch: Regeneron, UPS, and Zebra Regeneron (REGN) has seemingly overcome its bear phase, with shares rebounding from $550-$575 to over $650, a 12% increase, after reporting a 0.8% r…
Market Watch: Regeneron, UPS, and Zebra Regeneron (REGN) has seemingly overcome its bear phase, with shares rebounding from $550-$575 to over $650, a 12% increase, after reporting a 0.8% r…
European Parliament Considers Banning Russian Media The European Parliament is weighing whether to ban access to Russian websites, such as…
Anteris Reports Positive Biomimetic Heart Valve Study Results Anteris Technologies (Nasdaq:AVR) announced one-year clinical outcomes for i…
Regeneron's Eylea HD Rejected by FDA Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in Ja…
Eddie Glaude Jr. on Challenging MAGA Eddie Glaude Jr. suggests a simple response to false claims made by Trump supporters: "You're lying."…
Landmark Report Exposes Conflict of Interest in Canadian Lobbying A recent study by FMinus reveals that Canadian lobbyists represent both …
Preventing Infections after Surgery for Lower Limb Arteries Peripheral artery disease (PAD) is a condition where the arteries that supply …
PSG Look to Extend Lead in Ligue 1 Paris St Germain had a successful weekend, winning 3-0 away at Brest and taking the top spot in the tab…